Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-13 Kim Lorence H. Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-06-13 Pomerantz Roger Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-06-13 AFEYAN NOUBAR Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-06-13 Dere Willard H Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-06-13 Behar Gregory Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-06-13 Graves Kurt Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-06-13 Kender Richard N Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-06-13 Ausiello Dennis A Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-06-13 Zausner Meryl Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-01-28 DesRosier Thomas Chief Legal Officer and EVP Sale −5,471 $5.75 $31K 16,054
2019-01-28 Shaff Eric D. Sale −4,378 $5.75 $25K 12,842
2019-01-26 DesRosier Thomas Chief Legal Officer and EVP Exercise or conversion +15,000 21,525
2019-01-26 DesRosier Thomas Chief Legal Officer and EVP Exercise or conversion · RESTRICTED STOCK UNITS −15,000 25,000
2019-01-26 Shaff Eric D. Exercise or conversion +12,000 17,220
2019-01-26 Shaff Eric D. Exercise or conversion · RESTRICTED STOCK UNITS −12,000 20,000
2019-01-26 Aunins John G. Chief Technology Officer Exercise or conversion +7,500 92,750
2019-01-26 Aunins John G. Chief Technology Officer Exercise or conversion · RESTRICTED STOCK UNITS −7,500 12,500
2019-01-26 COOK DAVID N Exercise or conversion +7,500 147,435
2019-01-26 COOK DAVID N Exercise or conversion · RESTRICTED STOCK UNITS −7,500 12,500
2019-01-25 HORGAN KEVIN Chief Medical Officer and EVP Grant or award · STOCK OPTION (RIGHT TO BUY) +30,000 30,000

Page 25 of 34 · 662 trades